Why the study?
Hypertension often stems from resistance arteries endothelial dysfunction, and the hypothesis was tested that perivascular adipose tissue senescence contributes to vascular dysfunction and hypertension during aging.
Answers are grounded in this paper and cite their sources.
Perivascular adipose tissue senescence contributes to age-related vascular dysfunction and hypertension through downregulation of eNOS and upregulation of NADPH oxidase and COX-2.
Aging is a major risk factor for cardiovascular disease, with hypertension being the most common outcome. Hypertension often stems from resistance arteries endothelial dysfunction. Recent research highlights the pivotal role of perivascular adipose tissue (PVAT) in regulating endothelial function. We hypothesized that PVAT senescence contributes to vascular dysfunction and hypertension during aging. We showed that naturally aged mice developed hypertension and elevated pro-inflammatory cytokines levels. Moreover, resistance mesenteric arteries showed impaired vascular relaxation that was normalized by apocynin, an antioxidant. The vascular dysfunction was endothelium- and PVAT-dependent, and marked by: decreased nitric oxide- and cyclooxygenase-dependent vascular relaxation, decreased expression of endothelial nitric oxide synthase, and increased cyclooxygenase 2 and NADPH oxidase subunits p22phox and gp91phox expressions in the endothelium and PVAT. Additionally, we observed that PVAT shows greater signs of senescence, particularly with higher p16 expression, indicating that PVAT is more prone to age-related cellular aging. Our findings suggest that in resistance mesenteric arteries PVAT-derived factors are crucial for triggering and amplifying vascular dysfunction in aging, leading to hypertension. The underlying mechanisms involve downregulation of endothelial nitric oxide synthase-derived nitric oxide, NADPH oxidase-dependent oxidative stress, and cyclooxygenase 2-derived vascular contractile factors. This research improves our understanding of the mechanisms behind age-related vascular dysfunction and associated hypertension and opens perspectives for targeted therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: